explore -WSS

explore

author：leisure time 2025-09-02 08:23:54 - browse：99189

Two researchers look at a projection screen displaying medical devices, scientific graphs and DNA — health tech coverage from STAT — Adobe

The federal government’s plan to boost its oversight of the use of artificial intelligence tools in health care drew censure from startups arguing that overregulation stifles new ideas. But as Washington forges ahead, founders say they’re in the dark about who will be regulated and how — and they’re urging policymakers to offer clarity.

As they race for a slice of the $4 trillion U.S. health care market, AI founders and investors say regulatory uncertainty is a hurdle, forcing them to build more slowly and meticulously document for fear of potential audits. That makes it harder to keep up with the tech industry’s breakneck pace, they tell STAT.

The regulatory uncertainty adds to the many challenges dogging young health tech ventures today: Last year investments in digital health startups shriveled to their lowest annual total since 2019, and leaders are desperate to preserve what little funds they have, including through layoffs.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Moonlake's readout produced a cash windfall. Risks remain
Next article： Covid’s new normal has set in amid another rise in cases

hotspot

WSS

Ukraine seeks to reclaim its role as a hub for clinical trials

WATCH: Why do our ears pop?

Researchers tackle phage therapy hurdles for wider adoption

Weight loss drugs aren’t covered by Obamacare. That may change

Abridge raises $150m as clinical notes automation market heats up

Readout Newsletter: Bayer, Rapt Therapeutics, Sanofi shortage

leisure time

explore

hotspot

DIEP, the 'gold standard' of breast reconstruction, is under threat

Ukraine seeks to reclaim its role as a hub for clinical trials

The Supreme Court will review a ruling striking down a domestic violence federal gun ban

New study raises questions about niacin and heart health

New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum

New study raises questions about niacin and heart health

23andMe had bad news about my health. I wish a person had delivered it

Medicare Advantage enrollment grows 7.1% to 33.4 million people

United colonoscopy coverage change 'may cost lives,' doctors say

Fed up with FDA, ALS advocates consider a take

Wikipedia

AbbVie CEO Gonzalez to step down after a decade fiercely defending Humira

Bankrupt Pear's prescription app helped MassHealth save money, data suggests

FDA warns medical device makers about rise in fabricated data

Medicare Advantage enrollment grows 7.1% to 33.4 million people

Bipartisan group of lawmakers warns of a rising Chinese threat to U.S. biotech

Grad students accuse University of California of wage theft

focus

entertainment

hotspot

focus